Failure to Oversee Psychotropic Drug Use and Gradual Dose Reductions
Summary
The facility's Medical Director (MD 1) failed to oversee care area concerns related to psychotropic drug use and Gradual Dose Reductions (GDR) for 38 out of 83 residents currently receiving psychotropic medications. As a result, these residents did not have their psychotropic medications evaluated monthly, and their care needs were not addressed in a timely manner. There were no psychotropic care conferences, and no GDRs were attempted for nine months. This lapse in oversight could potentially be harmful to residents, as the medications have side effects that need regular monitoring and adjustment. During an interview, MD 1 admitted that the management team, which he led, was expected to meet monthly to evaluate nonpharmacological interventions, determine the amount of behaviors exhibited, and assess the number of side effects displayed. However, MD 1 acknowledged that the facility had fallen behind in conducting these reviews and GDRs. The facility's Medical Directorship Agreement and the Medical Director Duties outlined the responsibilities of the MD, including the supervision and oversight of health services and the review of residents' conditions and medication regimens. Despite these outlined duties, the MD admitted that since the facility changed ownership, psychotropic medications were not a primary focus, leading to the deficiency.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release May 27, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



